The Wall Street Journal's 2008 CEO compensation survey is out. Most of the pharma CEOs make in the $16 million to $18 million range, and the highest-paid person on the list of pharma execs is Abbott's Miles White, who receives a little more than $18 million. Eli Lilly's new CEO, John Lechleiter, may feel a little shafted with a compensation package worth about $10 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.